Paul Capital Partners

Carbon Black, Inc. is a cybersecurity company that offers advanced security solutions to clients in the United States and internationally. Founded in 2002 and headquartered in Waltham, Massachusetts, the company provides a comprehensive platform known as the Cb Predictive Security Cloud, which leverages big data and analytics to enhance endpoint security. Carbon Black's suite of products includes endpoint detection and response solutions, antivirus software, threat hunting services, and real-time security operations capabilities. Its offerings help organizations predict, prevent, detect, respond to, and remediate cyber threats, including malware and ransomware attacks. The company serves a diverse clientele, including security-focused enterprises, government agencies, and small to mid-sized organizations. In January 2016, Carbon Black changed its name from Bit9, Inc. and has since established itself as a leader in the cybersecurity industry, providing innovative solutions to protect critical systems and data. As of October 2019, Carbon Black operates as a subsidiary of VMware, Inc.

Recyclebank is a company dedicated to promoting sustainable living by incentivizing individuals for their eco-friendly actions. Through its platform, Recyclebank engages users in environmental awareness by offering rewards, such as discounts and deals from various local and national businesses, for completing specific challenges related to recycling and sustainability. By encouraging participation in green initiatives, Recyclebank aims to foster a culture of sustainability, helping individuals and communities realize the importance of reducing waste and increasing recycling rates.

Tethys BioScience, Inc. is focused on the discovery, development, and commercialization of biological markers for diagnosing metabolic diseases, particularly diabetes. The company has developed the PreDx Diabetes Risk Test, which evaluates a combination of proteins and other blood-borne biomarkers associated with diabetes risk. Founded in 2002, Tethys BioScience is headquartered in Emeryville, California.

Phase III Development is a Software Engineering company with expertise in a wide variety of development technologies. The mission is to provide customers with innovative custom software solutions of superior quality. They deliver on budget and on time.

UCB SA is a biopharmaceutical company headquartered in Brussels, Belgium, specializing in the development of therapies for neurology and immunology diseases. The company offers a range of products, including Cimzia for inflammatory conditions, Vimpat and Briviact for epilepsy, and Neupro for Parkinson's disease. Additionally, UCB produces Nayzilam, a nasal spray for seizure clusters, and Evenity for osteoporosis. Its pipeline includes promising treatments like padsevonil for drug-resistant epilepsy and rozanolixizumab for myasthenia gravis. UCB is also engaged in contract manufacturing and has established collaboration agreements with several pharmaceutical companies, including Sanofi and Amgen. Founded in 1928, UCB has a strong focus on research and development aimed at improving patient outcomes for individuals living with severe diseases, underlining its commitment to advancing medical science and patient care.

SpePharm is a European specialty pharmaceutical company focused on acquiring, registering, and marketing high-value medicines primarily for the hospital market. The company specializes in oncology, hematology, and supportive care, offering medical products that assist clinicians in managing oral complications associated with radiotherapy or chemotherapy. SpePharm's management team possesses extensive global experience in the pharmaceutical sector, particularly with a deep understanding of the European regulatory landscape and the nuances of niche and orphan products. Their expertise allows them to implement innovative strategies and achieve notable successes in the field.

On-X Life Technologies Inc. specializes in the development, manufacturing, and marketing of artificial heart valve replacement and repair products. The company's diverse product portfolio includes aortic and mitral heart valves equipped with standard, anatomic, and Conform-X sewing rings, as well as ascending aortic prostheses and chordal repair products. Additionally, On-X offers cardiovascular specialty products and provides technical services related to carbon-based technology, encompassing medical design, product development, and manufacturing. Founded in 1994 and based in Austin, Texas, the company was previously known as Medical Carbon Research Institute and rebranded in 2007. As of January 2016, On-X operates as a subsidiary of CryoLife Inc.

Acorda Therapeutics is a biopharmaceutical company focused on developing and commercializing therapies for neurological disorders in the United States and internationally. The company’s primary product, Ampyra (dalfampridine), is an oral medication approved to enhance walking in patients with multiple sclerosis. Additionally, Acorda markets Inbrija, an inhalation powder for the treatment of OFF periods in individuals with Parkinson's disease. The company's pipeline includes rHIgM22, which has completed Phase I trials for multiple sclerosis, and Cimaglermin alfa, currently in Phase Ib trials for heart failure. Acorda has established a collaboration with Biogen for the development and commercialization of Ampyra. Founded in 1995 and based in Ardsley, New York, Acorda Therapeutics aims to improve the quality of life for those affected by neurological conditions.

Prism Pharmaceuticals, Inc. is an acute care pharmaceutical company based in King of Prussia, Pennsylvania, founded in 2004. The company specializes in the development and commercialization of cardiovascular injectable products specifically for the United States market. Its notable offerings include NEXTERONE, an injectable antiarrhythmic agent, and PM103, an intravenous formulation of clopidogrel bisulfate.

Verus Pharmaceuticals is a pediatric-oriented company that identifies, develops, and delivers solutions to address the unmet medical needs of children and those who care for them. It offers treatment of asthma, allergies, and related diseases and conditions. The company also offers Twinject, an epinephrine auto-injector for anaphylaxis. Verus Pharmaceuticals is based in San Diego, California.

Roxy is a female sports fashion clothing brand based in Costa Mesa, California, specializing in a variety of apparel and accessories. The brand offers an extensive online shop where customers can purchase clothing items such as dresses, tops, tees, tanks, hoodies, jackets, and loungewear, as well as swimwear, shoes, and a range of accessories including handbags, backpacks, hats, and gloves. Roxy focuses on providing a diverse selection of products to meet the needs and budgets of its customers, catering to those interested in sports and active lifestyles.

eVentures Group operates and invests in internet communications companies.